Polypharmacy, commonly defined as taking five or more medications daily, is a significant health care concern impacting over 30% of older adults.
Single-dose genetic medicine halts the progression of ALS and frontotemporal dementia in mice
Neuroscientists at Macquarie University in Australia have developed a single-dose genetic medicine that has been proven to halt the progression of both ALS and frontotemporal